Anivive
Anivive Lifesciences is developing innovative pet health solutions, including a vaccine for Valley Fever and treatments for various diseases, using AI-powered technology to accelerate drug development.
Services
Anivive Lifesciences offers a variety of pet health solutions including the development of vaccines, treatments for cancer, fungal diseases, and viral infections. The company's platform Engage helps manage clinical studies, matching pets to trials based on medical needs, and accelerating study enrollment. Additionally, Anivive provides continuing education events for veterinary professionals through on-demand and live sessions.
Products
Anivive develops multiple products designed to address pet health, such as the Carbon DNA Kit, which provides insights into a pet's genetic predispositions to health issues. The company is also progressing the Valley Fever vaccine and investigational treatments for conditions like FIP with GC376, Hemangiosarcoma with eBAT, Blastomycosis, Gingivitis, Osteosarcoma, and pulmonary coccidioidomycosis. Moreover, they are focused on making medicines more affordable using AI-powered technology and innovative manufacturing processes.
Technology
Anivive uses advanced technologies to accelerate drug development. Their imaging module utilizes deep convolutional neural networks to detect systemic fungal infections in dogs. Additionally, AI-powered tools are used throughout the company's processes to bring new treatments and vaccines to market more efficiently. Anivive’s platforms, such as Engage, enhance the management and efficiency of clinical studies, allowing for faster patient accrual and more detailed data collection.
Sustainability Efforts
Anivive is committed to reducing waste and environmental impact. The company uses recycled materials in product packaging and collateral to promote sustainability within the pet health industry. This dedication demonstrates Anivive's commitment to environmentally responsible practices in all aspects of their operations.